Global Molecular Spectroscopy Market is expected to reach USD 6,443.5 million by 2024, from USD 3,959.8 million in 2016, growing at a CAGR of 6.3% in the forecast period. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
In 2016, Bruker dominates the market with 27.3% market share followed by Thermofisher Scientific, Inc. and, Agilent Technologies. Some of the major players operating in the global molecular spectroscopy market are ABB, Avantes, Block Engineering, Carl Zeiss Spectroscopy GmbH, Cobalt Light Systems Ltd, Galaxy Scientific, Gasera, Ibsen Photonics, Industrial Test Systems, Inc., Kaiser Optical Systems, Inc., Keit Spectrometers, Magritek, EMD Millipore Corporation, PerkinElmer Inc., Raptor Photonics PLC, Shimadzu Corporation, Spectral Evolution, Viavi Solutions, WITec GmbH, B&W Tek, StellarNet, Si-WareSystems, Foss, Jasco, Inc. and, Jeol Ltd. among others.
Bruker Corporation was incorporated in 1960 and is headquartered in Billerica, U.S. The company manufactures scientific instruments to focus on the needs of customers in the life science, pharmaceutical, biotechnology,clinical and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications. The company’s technology platforms include magnetic resonance technologies, mass spectrometry technologies, gas chromatography technologies, X-ray technologies, spark optical emission spectroscopy, atomic force microscopy, stylus and optical metrology technology, and infrared and Raman molecular spectroscopy technologies.
In May 2016, Bruker launched the EMX nanosystem at the 56th annual Experimental Nuclear Magnetic Resonance Conference(ENC). EMXnano is the first high-performance benchtop EPR (electron para magnetic resonance) instrument, making research-grade EPR capabilities accessible to a broader range of scientists.
In April 2015, Bruker launched the compact research grade Raman microscope SENTERRA II replacing the successful former model SENTERRA. The SENTERRA II defines a new level of performance and user friendliness inits class of compact Raman microscopes.
In March 2015, Bruker launched the first next generation,hand-held Raman spectrometer with patented fluorescence mitigation SSE (Sequentially Shifted Excitation) Bravo. This device now enables measurements of a wider range of raw materials, compared to first-generation systems. Specifically designed for the pharmaceutical industry, BRAVO’s intuitiveuser interface and touchscreen provide a superior guided workflow.
Thermo Fisher Scientific, Inc. was founded in the year 2006 through the merger of Thermo Electron and Fisher Scientific. It is headquartered at Waltham, U.S. Thermo Fisher Scientific, Inc. provides analytical instruments,equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics.The company operates its business through four segments: Analytical Technologies, Specialty Diagnostics, LifeSciences Solutions and Laboratory Products and Services. The Analytical Technologies segment provides a broadoffering of instruments, reagents, consumables, software and services that are used for a range of applications inthe laboratory on the production line and in the field. The Specialty Diagnostics segment offers a wide range of diagnostic test kits, reagents, culture media, instruments and associated products in order to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The Life-Sciences Solutions segmentenable, simplify and accelerate a broad spectrum of biological research of genes, proteins and cells within academic and life science research, clinical research and commercial applications. The Laboratory Products and Services segment offers virtually everything needed for the laboratory.
Agilent Technologies provides core bio-analytical and electronic measurement solutions to the life sciences, chemical analysis, communications and electronics, diagnostics and genomics industries. It operates through the following segments: Life Sciences, Chemical Analysis, Diagnostics & Genomics and Electronic Measurement. The Life Sciences segment provides application-focused solutions that include instruments, software, consumables and services that enable customers to identify quantify and analyze the physical and biological properties of substances and products.